Anzeige
Mehr »
Login
Samstag, 22.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
851 % Rendite in 30 Tagen: Die KI-Aktie, die seit der Integration von Deepseek R1 Wellen schlägt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0B7QK | ISIN: GB0034330679 | Ticker-Symbol: DWV
Berlin
21.02.25
19:27 Uhr
0,151 Euro
0,000
0,00 %
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
ANGLE PLC Chart 1 Jahr
5-Tage-Chart
ANGLE PLC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1440,15813:03

Aktuelle News zur ANGLE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
29.01.Angle PLC Announces Analysis of CTC-DNA and ctDNA using Illumina assay227NEW RESULTS FOR dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platformFindings in lung cancer show that CTCs can provide additional biomarkers not found in ctDNA from single...
► Artikel lesen
ANGLE Aktie jetzt für 0€ handeln
24.01.Angle's Parsortix system used in 'breakthrough' breast cancer research1
24.01.Angle PLC Announces Parsortix Used in Research Paper from ETH Zurich214CLINICAL TRIAL POWERED BY PARSORTIX SYSTEM PROVIDES FIRST-IN-CLASS data FOR NOVEL APPROACH TO CANCER treatmentParsortix system used to identify patients with highly metastatic CTC clusters for targeted...
► Artikel lesen
23.01.Broker tips: Spectris, Inchcape, AutoTrader, JD Sports, Angle8
23.01.Angle fails to win market confidence despite narrowing loss in 20242
23.01.Berenberg slashes target price on Angle3
23.01.Angle PLC Announces Trading Update448Revenue for 2024 expected to be up 31%Lower cost base going into 2025 with a growing sales pipeline of opportunities GUILDFORD, SURREY / ACCESS Newswire / January 23, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY)...
► Artikel lesen
13.12.24Angle PLC Announces HER2 Presentation at SABCS306WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUMIndependent findings support ANGLE's HER2 assay development programmePotential for stratification of breast...
► Artikel lesen
15.11.24Angle stock surges as firm showcases new assay products7
15.11.24Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR203CTC PD-L1 assay enables longitudinal monitoring of PD-L1 status in lung cancer patients and may help to advance personalised treatment GUILDFORD, UNITED KINGDOM / ACCESSWIRE / November 15, 2024 / ANGLE...
► Artikel lesen
15.11.24Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR199RESULTS FROM WORK TO DEVELOP A PARSORTIX-BASED Her2 assay KIT SHOWCASED AT INTERNATIONAL LIQUID BIOPSY CONFERENCEParsortix-based HER2 kit being developed to provide an optimised, easily implemented...
► Artikel lesen
14.11.243 Ways Investors Angle To Profit From Trump's Next Four Years1
13.11.24ANGLE plc: ANGLE presents two posters at EACR202PARSORTIX-BASED ASSAYS SHOWCASED AT THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH LIQUID BIOPSIES CONFERENCETwo posters highlight the importance of epitope-independent CTC enrichment and molecular characterisation...
► Artikel lesen
11.11.24Angle notes use of Parsortix system in treatment resistance study-
11.11.24Angle PLC Announces Parsortix enriched CTC & ctDNA in NSCLC patients270ANGLE plc ("the Company")DNA ANALYSIS OF PARSORTIX-ENRICHED CTCS AND CTDNA PROVIDES COMPLEMENTARY INFORMATION IN NSCLC PATIENTS TREATED WITH ASTRAZENECA'S OSIMERTINIBThe addition of CTC-DNA analysis...
► Artikel lesen
17.10.24Angle PLC Announces Publication Demonstrates CTC Profiling Potential200PUBLICATION DEMONSTRATES POTENTIAL FOR multi-marker CTC profiling IN EARLY PROSTATE CANCERParsortix enriched CTCs detected at high rates in localised diseaseMulti-marker profiling of CTCs could support...
► Artikel lesen
26.09.24Angle Plc reports 1H results2
26.09.24Angle PLC Announces 100th Publication Supporting Parsortix System Use265GUILDFORD, SURREY / ACCESSWIRE / September 26, 2024 / Whole Genomic Sequencing and machine learning identifies key cancer genes associated with DNA proliferation and repairANGLE plc (AIM:AGL)(OTCQX:ANPCY)...
► Artikel lesen
26.09.24Angle PLC Announces Half-year Report212Interim Results for the six months ended 30 June 2024LARGE PHARMA STRATEGY IMPLEMENTED SUCCESSFULLYThree Large Pharma contracts secured each with substantial revenue potentialStrategic decision post...
► Artikel lesen
23.09.24ANGLE Enters Agreement With NuProbe; Gets Worldwide Licence Option For NGS Panel-
Seite:  Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1